2015 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
12/17/15West Announces Quarterly Dividend and Share Repurchase Program
EXTON, PA -- (Marketwired) -- 12/17/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be paid on February 3, 2016 to shareholders of record as of January 20, 2016. The Company also announced a share repurchase program authorizing the repurchase of up to 700,000 shares of the Company's common stock from time to time on the open market or in privately negoti... 
Printer Friendly Version
11/19/15West Appoints George L. Miller Senior Vice President, General Counsel and Corporate Secretary
EXTON, Pa., Nov. 19, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed George L. Miller to serve as Senior Vice President, General Counsel and Corporate Secretary, effective November 19, 2015. Mr. Miller will serve on the senior leadership team and will oversee the Company's global legal function and corporate governance.  Most recently, Mr. Miller served as Sr. V... 
Printer Friendly Version
11/02/15West to Showcase Self-injection Systems and Prefillable Syringe Component Expertise at the PDA Universe of Pre-filled Syringes and Injection Devices
Expert panels and presentations offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing VIENNA, Nov. 2, 2015 /PRNewswire/ -- (Booth #45-46) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will participate in several educational sessions and showcase innovative West product offerings at the Parenteral Drug Association (PDA) Universe of Pre-filled S... 
Printer Friendly Version
10/29/15West Announces Third Quarter 2015 Results
Reports Sales of $344.5 million and Adjusted Diluted EPS of $0.44 -- Raises Full-Year 2015 Adjusted Diluted EPS to Range of $1.79 to $1.84 -- Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 10/29/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2015 and updated financial guidance for the full year 2015. Executive Summary Third quarter 2015 reported sales of $344.5 million were 3.2% bel... 
Printer Friendly Version
10/22/15West to Host Third Quarter 2015 Conference Call
EXTON, PA -- (Marketwired) -- 10/22/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter 2015 financial results before the market opens on Thursday, October 29th, 2015, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 60682964. A live broadcast of the conference call ... 
Printer Friendly Version
10/13/15West Launches New Ready-to-Use/Validated Components at CPhI/InnoPack 2015
MADRID, Oct. 13, 2015 /PRNewswire/ -- (Booth #4G30) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative systems and component solutions for injectable drug administration, today launched Daikyo RUV® (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe 2015 in Madrid, Spain. In addition, West is showcasing a range of the company's products, which demonstrate how drug delivery and packaging solutions can support pharmaceutical manufacturers to provide ... 
Printer Friendly Version
09/30/15West Appoints Annette Favorite Senior Vice President and Chief Human Resources Officer
EXTON, Pa., Sept. 30, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Annette Favorite to serve as Senior Vice President and Chief Human Resources Officer, effective October 5, 2015. In this role, Ms. Favorite will serve on the senior executive team, reporting to Eric Green, Chief Executive Officer, and will oversee the company's global human resources function. ... 
Printer Friendly Version
09/17/15West Pharmaceutical Services, Inc. and HealthPrize Technologies Announce Self-Reporting and Barcoding Capabilities for Self-Injection Technology
Connected health leaders complete first two phases of medication adherence collaboration EXTON, Pa., Sept. 17, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC, today announced the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient-engagement platform with West's injectable drug delivery systems t... 
Printer Friendly Version
09/10/15West to Purchase Group Annuity Contract for Retiree Pension Benefits
Reduces Pension Obligation by 44% EXTON, PA -- (Marketwired) -- 09/10/15 -- West Pharmaceutical Services, Inc. ("West") (NYSE: WST) today announced that it has entered into an agreement to purchase a group life annuity contract from Metropolitan Life Insurance Company (MetLife) to settle approximately $140 million, or 44% of its approximately $315 million of outstanding U.S. pension obligations. MetLife will assume the obligations to pay future pension benefits starting November 1, 2015, for ... 
Printer Friendly Version
09/02/15West to Present at Upcoming Investor Conferences
EXTON, PA -- (Marketwired) -- 09/02/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: CL King's 13th Annual Best Ideas Conference, New York, NY Thursday, September 10, 2015 at 1:15 PM Eastern Time Morgan Stanley Global Healthcare Conference 2015, New York, NY Wednesday, Se... 
Printer Friendly Version
07/30/15West Announces Second Quarter 2015 Results
Delivers Sales of $359.7 Million and Adjusted Diluted EPS of $0.47. Raises Lower-End of Full-Year 2015 Adjusted Diluted EPS to a New Range of $1.74 to $1.84 -- Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 07/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2015 and updated financial guidance for the full year 2015. Executive Summary Reported sales of $359.7 million declined 2.5%... 
Printer Friendly Version
07/23/15West to Host Second Quarter 2015 Conference Call
EXTON, PA -- (Marketwired) -- 07/23/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release second quarter 2015 financial results before the market opens on Thursday, July 30, 2015, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 86053988. A live broadcast of the conference call wil... 
Printer Friendly Version
07/20/15West Expands Manufacturing Capacity at Scottsdale Facility to Support Customer Demand for SmartDose® Electronic Wearable Injector
Patient-friendly wearable injector utilized in multiple active drug development programs EXTON, Pa., July 20, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has expanded capabilities at its Scottsdale, Ariz. facility to meet increased customer demand for the SmartDose® Electronic Wearable Injector. The expansion in Scottsdale will enable continuing development and produc... 
Printer Friendly Version
07/14/15West Announces Increase to Quarterly Dividend
EXTON, PA -- (Marketwired) -- 07/14/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a fourth-quarter 2015 dividend of $0.12 per share, a 9.1% increase over the $0.11 per share declared for each of the four preceding quarters. This is the twenty-third consecutive annual increase in the Company's dividend. The fourth-quarter dividend will be paid on November 4, 2015 to shareholders of record as of October 21, 2015. About W... 
Printer Friendly Version
07/01/15West Announces Quarterly Dividend
EXTON, PA -- (Marketwired) -- 07/01/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company will pay a third-quarter 2015 dividend of $0.11 per share. The dividend will be paid on August 5, 2015 to shareholders of record as of July 22, 2015. About West West Pharmaceutical Services is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West... 
Printer Friendly Version
06/16/15West Celebrates Groundbreaking of Waterford, Ireland Manufacturing Facility
Deepens investment in Ireland to support growing global customer demand WATERFORD, Ireland, June 16, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative packaging components and drug delivery systems, hosted a groundbreaking ceremony in Waterford, Ireland today to mark the start of construction for the company's new pharmaceutical component manufacturing facility. Attended by Cllr James Tobin, Mayor of Waterford City and County; Cll... 
Printer Friendly Version
05/27/15West to Present at Jefferies Conference
EXTON, PA -- (Marketwired) -- 05/27/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at Jefferies 2015 Healthcare Conference, New York, NY at 10:30 a.m. ET on Wednesday, June 3rd, 2015. A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors. About West West Pharmaceutical Servic... 
Printer Friendly Version
05/12/15West Bolsters R&D Strategy with Global Site Expansions & Upgrades
EXTON, Pa., May 12, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative packaging components and drug delivery systems, today announced a multi-year investment as part of the Company's evolving research and development strategy. To better support pharmaceutical customers around the world, West will add capabilities to all of its global Packaging Systems R&D facilities, and develop two new R&D Centers of Excellence—one in the Asia Pacific reg... 
Printer Friendly Version
05/06/15West to Present at Upcoming Investor Conferences
EXTON, PA -- (Marketwired) -- 05/06/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at each of the following conferences: Bank of America Merrill Lynch 2015 Global Health Care Conference, Las Vegas, NV Wednesday, May 13, 2015 at 2:20 p.m. PT UBS Global Healthcare Conference, New York, NY Monday, May 18, 2015 at 3:30 p.m. ET A live audio webcast of the presentations, as we... 
Printer Friendly Version
04/30/15West Announces First Quarter 2015 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 04/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2015 and updated financial guidance for the full year 2015. Highlights Improved sales mix fuels wider gross margin and 21.6% growth in operating profit First-quarter diluted EPS rose 18.4% to $0.45 per share Reported sales declined 3.1% due to currency ... 
Printer Friendly Version
04/23/15REMINDER: West to Host First Quarter 2015 Conference Call
EXTON, PA -- (Marketwired) -- 04/23/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release first quarter 2015 financial results before the market opens on Thursday, April 30, 2015, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 27364666. A live broadcast of the conference call wil... 
Printer Friendly Version
04/15/15Eric Green Appointed Chief Executive Officer of West Pharmaceutical Services
EXTON, PA -- (Marketwired) -- 04/15/15 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Eric M. Green has been appointed the company's Chief Executive Officer, succeeding Donald E. Morel, Jr., Ph.D., current Chairman and CEO. Eric Green will join West and take on his new responsibilities on April 24, 2015. Dr. Morel will serve as West's Chairman following Eric Green's appointment, until July 1, ... 
Printer Friendly Version
03/05/15West to Present at Barclays Conference
EXTON, PA -- (Marketwired) -- 03/05/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the Barclays Global Healthcare Conference, Miami, FL at 2:05 p.m. ET on Thursday, March 12th, 2015. A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors. About West West Pharmaceutical Servi... 
Printer Friendly Version
02/20/15West Announces Quarterly Dividend
EXTON, PA -- (Marketwired) -- 02/20/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2015 dividend of $0.11 per share. The dividend will be paid on May 6, 2015 to shareholders of record as of April 22, 2015. About West West Pharmaceutical Services is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from ... 
Printer Friendly Version
02/19/15West Announces Fourth Quarter and Full Year 2014 Results
Conference Call Scheduled for 9 a.m. Today EXTON, PA -- (Marketwired) -- 02/19/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year 2014 and provided annual financial guidance for 2015. Highlights Fourth-quarter sales grew 7.4% excluding currency effects and disposition Fourth-quarter adjusted diluted EPS rose 18% to $0.45 per share Reported EPS increased to... 
Printer Friendly Version
02/12/15West to Host Fourth Quarter and Full Year 2014 Conference Call
EXTON, PA -- (Marketwired) -- 02/12/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2014 financial results before the market opens on Thursday, February 19, 2015 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-474-9505 (U.S.) or 857-244-7558 (International). The passcode is 21690107. A live broadcast of the confere... 
Printer Friendly Version
02/11/15West Launches High-Quality Flip-Off® PlusRU Seals
Sterile, ready-to-use drug vial seals help pharmaceutical and biopharmaceutical manufacturers meet regulatory challenges and ensure drug safety EXTON, Pa., Feb. 11, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of a new sterile drug vial seal, the Flip-Off® PlusRU seal. Part of West's Flip-Off® seal product family, these new ready-to-use seals help pharmaceutic... 
Printer Friendly Version
01/09/15West to Present at Upcoming Investor Conference
EXTON, PA -- (Marketwired) -- 01/09/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the 33rd Annual J.P. Morgan Healthcare Conference, San Francisco, CA at 8:00 a.m. PT on Thursday, January 15th, 2015. A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors. About West West is by the s... 
Printer Friendly Version
West Pharma Callout
Contact Investor Relations